GlassScriptPhysician profile
Irwin S Plisco
NPI 1871574525
$7,493.41
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,393 · 2020: $1,956 · 2021: $1,169 · 2022: $913 · 2023: $838 · 2024: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $928.99 | 2019-2024 | Mounjaro, Zepbound, Emgality |
| Abbvie INC. | $880.22 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $867.57 | 2019-2024 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $546.74 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $475.26 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $446.99 | 2019-2023 | Xarelto |
| Pfizer INC. | $408.56 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $396.76 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $345.77 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.04 | 2019-2023 | Synjardy, Jardiance |
| Astellas Pharma US INC | $204.00 | 2019-2021 | |
| Grifols USA, LLC | $184.63 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $164.04 | 2019-2023 | Xifaxan |
| Amgen INC. | $147.34 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $145.06 | 2019-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $117.09 | 2019 | |
| Arbor Pharmaceuticals, INC. | $95.54 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $93.97 | 2020 | |
| Dexcom, INC. | $90.49 | 2021-2022 | |
| Amarin Pharma, INC. | $77.42 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.09 | 2021-2023 | |
| Allergan, INC. | $47.49 | 2019-2020 | |
| Senseonics, Incorporated | $46.00 | 2019 | |
| Abbott Laboratories | $43.03 | 2019 | |
| Nestle Healthcare Nutrition INC. | $38.29 | 2023 | |
| Dermira, INC. | $37.14 | 2020 | |
| Esperion Therapeutics, INC. | $36.48 | 2020 | |
| Exact Sciences Corporation | $31.68 | 2024 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $26.73 | 2020-2021 | |
| Medtronic, INC. | $20.10 | 2023 | Intellis Adaptivestim |
| E.R. Squibb & Sons, L.L.C. | $17.50 | 2019 | |
| Apria Healthcare LLC | $17.36 | 2021 | |
| Gilead Sciences, INC. | $16.41 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $16.05 | 2022 | |
| Valeritas, INC. | $15.07 | 2019 | |
| Ascensia Diabetes Care US INC. | $14.95 | 2021 | |
| Aimmune Therapeutics, INC. | $14.84 | 2024 | |
| Insulet Corporation | $13.37 | 2019 | |
| Sanofi Pasteur INC. | $13.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irwin Plisco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.